Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Similar Journals
Journal Cover
Leukemia
Journal Prestige (SJR): 5.131
Citation Impact (citeScore): 6
Number of Followers: 21  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 0887-6924 - ISSN (Online) 1476-5551
Published by NPG Homepage  [143 journals]
  • Genomic abnormalities of TP53 define distinct risk groups of paediatric
           B-cell non-Hodgkin lymphoma

    • Free pre-print version: Loading...

      Leukemia, Published online: 21 October 2021; doi:10.1038/s41375-021-01444-6

      Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphomaLeukemia, Published online: 2021-10-21; doi:10.1038/s41375-021-01444-62021-10-21
      DOI: 10.1038/s41375-021-01444-6
       
  • AML with germline DDX41 variants is a clinicopathologically distinct
           entity with an indolent clinical course and favorable outcome

    • Free pre-print version: Loading...

      Leukemia, Published online: 20 October 2021; doi:10.1038/s41375-021-01404-0

      AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomeLeukemia, Published online: 2021-10-20; doi:10.1038/s41375-021-01404-02021-10-20
      DOI: 10.1038/s41375-021-01404-0
       
  • Allogeneic blood or marrow transplantation with haploidentical donor and
           post-transplantation cyclophosphamide in patients with myelofibrosis: a
           multicenter study

    • Free pre-print version: Loading...

      Leukemia, Published online: 18 October 2021; doi:10.1038/s41375-021-01449-1

      Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studyLeukemia, Published online: 2021-10-18; doi:10.1038/s41375-021-01449-12021-10-18
      DOI: 10.1038/s41375-021-01449-1
       
  • Prognostic impact of chromosomal abnormalities and copy number alterations
           in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

    • Free pre-print version: Loading...

      Leukemia, Published online: 16 October 2021; doi:10.1038/s41375-021-01448-2

      Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 studyLeukemia, Published online: 2021-10-16; doi:10.1038/s41375-021-01448-22021-10-16
      DOI: 10.1038/s41375-021-01448-2
       
  • Correction: PI3-kinase/Akt is constitutively active in primary acute
           myeloid leukaemia cells and regulates survival and chemoresistance via
           NF-kB, MAPkinase and p53 pathways

    • Free pre-print version: Loading...

      Leukemia, Published online: 15 October 2021; doi:10.1038/s41375-021-01440-w

      Correction: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathwaysLeukemia, Published online: 2021-10-15; doi:10.1038/s41375-021-01440-w2021-10-15
      DOI: 10.1038/s41375-021-01440-w
       
  • A comprehensive review of the impact of obesity on plasma cell disorders

    • Free pre-print version: Loading...

      Leukemia, Published online: 15 October 2021; doi:10.1038/s41375-021-01443-7

      A comprehensive review of the impact of obesity on plasma cell disordersLeukemia, Published online: 2021-10-15; doi:10.1038/s41375-021-01443-72021-10-15
      DOI: 10.1038/s41375-021-01443-7
       
  • Carfilzomib maintenance in newly diagnosed non-transplant eligible
           multiple myeloma

    • Free pre-print version: Loading...

      Leukemia, Published online: 14 October 2021; doi:10.1038/s41375-021-01415-x

      Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myelomaLeukemia, Published online: 2021-10-14; doi:10.1038/s41375-021-01415-x2021-10-14
      DOI: 10.1038/s41375-021-01415-x
       
  • Combined Drug Targeting of p53-dependent and -independent Pathways
           Depletes Myelofibrosis Hematopoietic Stem/Progenitor Cells

    • Free pre-print version: Loading...

      Leukemia, Published online: 12 October 2021; doi:10.1038/s41375-021-01446-4

      Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor CellsLeukemia, Published online: 2021-10-12; doi:10.1038/s41375-021-01446-42021-10-12
      DOI: 10.1038/s41375-021-01446-4
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.236.232.99
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-